Can pegylated IL-10 add to a backbone of PD-1 inhibition for solid tumours?

被引：5
|
作者：
Pal, Sumanta [1 ]
Hu-Lieskovan, Siwen [2 ]
Agarwal, Neeraj [2 ]
机构：
[1] City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA 91010 USA
[2] Univ Utah, Div Med Oncol, Huntsman Canc Inst, Salt Lake City, UT USA
来源：
LANCET ONCOLOGY | 2019年 / 20卷 / 11期
关键词：
NIVOLUMAB;
D O I：
10.1016/S1470-2045(19)30619-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1473 / 1474
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of pegylated human IL-10 (AM0010) in combination with an anti-PD-1 in renal cell cancer.
    Naing, Aung
    Infante, Jeffrey R.
    Jean, Deborah
    Wong, Lee
    Korn, Wolfgang Michael
    Aljumaily, Raid
    Papadopoulos, Kyriakos P.
    Autio, Karen A.
    Pant, Shubham
    Bauer, Todd Michael
    Drakaki, Alexandra
    Daver, Naval Guastad
    Hung, Annie
    Van Vlasselaer, Peter
    Brown, Gail Linda
    Oft, Martin
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] The role of programmed death 1 (PD-1) receptor, its ligands PD-L1 and PD-L2, and IL-10 in LP-BM5 induced MAIDS
    Green, KA
    Okazaki, T
    Honjo, T
    Green, WR
    FASEB JOURNAL, 2005, 19 (04): : A963 - A963
  • [23] Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients
    Giunta, Emilio Francesco
    Barra, Giusi
    De Falco, Vincenzo
    Argenziano, Giuseppe
    Napolitano, Stefania
    Vitale, Pasquale
    Zanaletti, Nicoletta
    Terminiello, Marinella
    Martinelli, Erika
    Morgillo, Floriana
    Ciardiello, Davide
    De Palma, Raffaele
    Ciardiello, Fortunato
    Troiani, Teresa
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [24] PD-1 and ICOS counter-regulate tissue resident regulatory T cell development and IL-10 production during flu
    McGee, Michael C.
    Zhang, Tianyi
    Magazine, Nicholas
    Islam, Rezwanul
    Carossino, Mariano
    Huang, Weishan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [25] Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients
    Emilio Francesco Giunta
    Giusi Barra
    Vincenzo De Falco
    Giuseppe Argenziano
    Stefania Napolitano
    Pasquale Vitale
    Nicoletta Zanaletti
    Marinella Terminiello
    Erika Martinelli
    Floriana Morgillo
    Davide Ciardiello
    Raffaele De Palma
    Fortunato Ciardiello
    Teresa Troiani
    Scientific Reports, 10
  • [26] Dual IL-10 and PD-1 blockade in SIVmac239 infected macaques promotes sustained virologic control in absence of ART
    Strongin, Z.
    Ribeiro, S. P.
    Hoang, T. N.
    Nguyen, K.
    Harper, J.
    Estes, J. D.
    Micci, L.
    Lifson, J. D.
    Howell, B. J.
    Gorman, D.
    Hazuda, D. J.
    Paiardini, M.
    Sekaly, R-P
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24 : 68 - 69
  • [27] Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours
    Valentina Martin
    Cristina Chiriaco
    Chiara Modica
    Anna Acquadro
    Marco Cortese
    Francesco Galimi
    Timothy Perera
    Loretta Gammaitoni
    Massimo Aglietta
    Paolo M. Comoglio
    Elisa Vigna
    Dario Sangiolo
    British Journal of Cancer, 2019, 120 : 527 - 536
  • [28] Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours
    Martin, Valentina
    Chiriaco, Cristina
    Modica, Chiara
    Acquadro, Anna
    Cortese, Marco
    Galimi, Francesco
    Perera, Timothy
    Gammaitoni, Loretta
    Aglietta, Massimo
    Comoglio, Paolo M.
    Vigna, Elisa
    Sangiolo, Dario
    BRITISH JOURNAL OF CANCER, 2019, 120 (05) : 527 - 536
  • [29] Efficacy and safety of combination PD-1/PD-L1 checkpoint inhibitors for malignant solid tumours: A systematic review
    Yao, Qigu
    Gu, Lihu
    Su, Rong
    Chen, Bangsheng
    Cao, Hongcui
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (22) : 13494 - 13506
  • [30] Relationship between IL-10 and PD-L1 in esophageal carcinoma tissues and IL-10 down-regulates PD-L1 expression via Met signaling pathway
    Qian, Qian
    Wu, Changping
    Chen, Jianping
    Wang, Weibing
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (02) : 337 - +
12345